Myeloma-bone marrow adipocyte axis in tumour survival and treatment response

Abbas Jafari*, Heather Fairfield, Thomas L. Andersen, Michaela R. Reagan

*Corresponding author for this work

Research output: Contribution to journalComment/debateResearchpeer-review


Multiple myeloma is an incurable cancer of the bone marrow that is dependent on its microenvironment, including bone marrow adipocytes (BMAds). Here, we discuss our findings that the reciprocal interaction of myeloma cells and BMAds, leads to myeloma cell survival and induces metabolic dysfunction and senescence-associated secretory phenotype in BMAds.

Original languageEnglish
JournalBritish Journal of Cancer
Issue number6
Pages (from-to)775-777
Publication statusPublished - Sep 2021

Bibliographical note

Publisher Copyright:
© 2021, The Author(s), under exclusive licence to Cancer Research UK.


Dive into the research topics of 'Myeloma-bone marrow adipocyte axis in tumour survival and treatment response'. Together they form a unique fingerprint.

Cite this